Yi Shu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yi Shu has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Haizhao Luo
Department of Endocrinology, Zhujiang Hospital, Southern Medical University, No. 253 Gong Ye Road, Guangzhou 510282, China ; Department of Endocrinology, Nanhai Hospital, Southern Medical University, No. 40 Foping Road, Foshan 528200, China
1 shared publication- He Tian
School of Integrated Circuits, Tsinghua University, Beijing, China
1 shared publication - Hong Chen
Department of Endocrinology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
1 shared publication Janwen Luo
Center for Biomedical Imaging Research, Tsinghua University, Beijing 100084, China
1 shared publicationMin Tang
Institute of Microelectronics, Tsinghua University, Beijing 100084, China
1 shared publicationQingtang Xue
Institute of Microelectronics, Tsinghua University, Beijing 100084, China
1 shared publication
Latest Publications
- Open Access
- 19 June 2015
- Published by Tsinghua University Press in Tsinghua Science and Technology
- Vol. 20 (3) , 264-269
K0.5Na0.5NbO3-based self-powered pressure sensor
We report a novel self-powered nanocomposite sensor composed of K 0.5 Na 0.5 NbO 3 (KNN) nanoparticles (NPs) and multiwalled carbon nanotubes (MW-CNTs). The KNN NPs and MW-CNTs are dispersed in polydimethylsioxane by mechanical agitation to produce a piezoelectric nanocomposite device. The device exhibits an output voltage of approximately 30 V and output current of approximately 15 μA. Furthermore, the device exhibits potential as a self-powered pressure sensor because the output voltage can be tested to detect the pressure applied to the device and does not require other sources.
- 19 June 2015
- Published by Tsinghua University Press in Tsinghua Science and Technology
- Vol. 20 (3) , 264-269
Open AccessK0.5Na0.5NbO3-based self-powered pressure sensor
We report a novel self-powered nanocomposite sensor composed of K 0.5 Na 0.5 NbO 3 (KNN) nanoparticles (NPs) and multiwalled carbon nanotubes (MW-CNTs). The KNN NPs and MW-CNTs are dispersed in polydimethylsioxane by mechanical agitation to produce a piezoelectric nanocomposite device. The device exhibits an output voltage of approximately 30 V and output current of approximately 15 μA. Furthermore, the device exhibits potential as a self-powered pressure sensor because the output voltage can be tested to detect the pressure applied to the device and does not require other sources.
- Open Access
- 19 May 2014
- Published by Wiley in Journal of Diabetes Research
- Vol. 2014, 1-7
Reprogramming of Mice Primary Hepatocytes into Insulin-Producing Cells by Transfection with Multicistronic Vectors
The neogenesis of insulin-producing cells (IPCs) from non-beta-cells has emerged as a potential method for treating diabetes mellitus (DM). Many groups have documented that activation of pancreatic transcription factor(s) in hepatocytes can improve the hyperglycemia in diabetic mice. In the present study, we explored a novel protocol that reprogrammed primary hepatocytes into functional IPCs by using multicistronic vectors carrying pancreatic and duodenal homeobox-1 (Pdx1), neurogenin 3 (Ngn3), and v-musculoaponeurotic fibrosarcoma oncogene homolog A (MafA). These triple-transfected cells activated multiple beta-cell genes, synthesized and stored considerable amounts of insulin, and released the hormone in a glucose-regulated manner in vitro. Furthermore, when transplanted into streptozotocin-induced diabetic mice, the cells markedly ameliorated glucose tolerance. Our results indicated that ectopic expression of Pdx1, Ngn3, and MafA facilitated hepatocytes-to-IPCs reprogramming. This approach may offer opportunities for treatment of DM.
- 19 May 2014
- Published by Wiley in Journal of Diabetes Research
- Vol. 2014, 1-7
Open AccessReprogramming of Mice Primary Hepatocytes into Insulin-Producing Cells by Transfection with Multicistronic Vectors
The neogenesis of insulin-producing cells (IPCs) from non-beta-cells has emerged as a potential method for treating diabetes mellitus (DM). Many groups have documented that activation of pancreatic transcription factor(s) in hepatocytes can improve the hyperglycemia in diabetic mice. In the present study, we explored a novel protocol that reprogrammed primary hepatocytes into functional IPCs by using multicistronic vectors carrying pancreatic and duodenal homeobox-1 (Pdx1), neurogenin 3 (Ngn3), and v-musculoaponeurotic fibrosarcoma oncogene homolog A (MafA). These triple-transfected cells activated multiple beta-cell genes, synthesized and stored considerable amounts of insulin, and released the hormone in a glucose-regulated manner in vitro. Furthermore, when transplanted into streptozotocin-induced diabetic mice, the cells markedly ameliorated glucose tolerance. Our results indicated that ectopic expression of Pdx1, Ngn3, and MafA facilitated hepatocytes-to-IPCs reprogramming. This approach may offer opportunities for treatment of DM.